OpenVSafe by OpenVAERS
Search V-safe

S4V-54341-82314

4 vaccinations 2 coded responses 20 check-ins 0 free-text entries 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
813 / CO
Registered
2021-12-23
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-03
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-24
    Dose 2 — Pfizer-BioNTech
  3. 2021-12-23
    Registered in v-safe
  4. 2021-12-23
    Dose 3 — Pfizer-BioNTech
  5. 2021-12-23
    Health check-in — day 0, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-12-24
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea
    Adult check-in
  7. 2021-12-26
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  8. 2021-12-27
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  9. 2021-12-28
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  10. 2021-12-29
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  11. 2021-12-30
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  12. 2022-01-07
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  13. 2022-01-13
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  14. 2022-01-20
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  15. 2022-01-27
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  16. 2022-02-05
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  17. 2022-03-25
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  18. 2022-06-23
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  19. 2022-11-16
    Dose 4 — Moderna
    Co-administered: Flu
  20. 2022-12-10
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  21. 2022-12-14
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  22. 2022-12-21
    Health check-in — day 35, dose 4
    Feeling: Fair
    Adult check-in
  23. 2022-12-28
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  24. 2023-02-15
    Survey response — 3 months, dose 4
    MedDRA: Cough, Headache, Malaise, Nasopharyngitis, Oropharyngeal pain, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    MedDRA releases: 2024-11
  25. 2023-05-17
    Survey response — 6 months, dose 4
    MedDRA: Cough, Nasal congestion, Oropharyngeal pain, Pain, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12021-03-03Pfizer-BioNTech No
22021-03-24Pfizer-BioNTech No
32021-12-23Pfizer-BioNTech No
42022-11-16Moderna Flu

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDHeadache · · ✓
SDMalaise · · ✓
SDNasal congestion · · ✓
SDNasopharyngitis · · ✓
SDOropharyngeal pain · · ✓
SDPain · · ✓
SDRespiratory tract congestion · · ✓
SDRhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release